Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Juan Cinca,
Investigators GF Tomaselli (Baltimore, USA), KR Sipido ( Leuven, BE), AW Trafford (Manchester,GB), and LS Maier (Göttingen, DE) reviewed the role of ionic channels, sarcoplasmic reticulum (SR), ryanodine receptors (RyR), Na + / Ca 2+ exchanger, and Ca 2+ /calmodulin-dependent protein kinase (CaMK) on ventricular arrhythmias linked to abnormal intracellular calcium handling and therefore, to abnormal membrane afterdepolarizations.
A micro-array expression profile in a dog model of rapid pacing-induced heart failure is feasible and allows to correlate the temporal gene expression with the evolving electrophysiological derangements (prolongation of action potential duration and slowing of conduction velocity). Heart failure is associated with abnormal SR calcium release, hyperphosphorylation of ryanodine receptors, activation of the Na + / Ca 2+ exchanger in the reverse mode, and overexpression and function of Ca MKII. Drugs that modulate the function of this calcium handling protein system may have the potential to exert antiarrhythmic effects. However, like CaMK (see figure), most of the calcium handling modulators exert their effects at various intracellular sites and cellular structures. Thus a better knowledge of these interactions is needed to develop drugs with a resultant net beneficial action. Moreover, most of our knowledge on the relationship between intracellular calcium and arrhythmogenesis linked to afterdepolarizations is based on experimental models of ventricular arrhythmias.
Since atrial arrhythmias such as atrial fibrillation are associated with abnormal SR calcium release and these can in turn be elicited by afterdepoplarizations, drugs that modulate intracellular calcium handling may have antiarrhythmic potential properties at both atrial and ventricular levels.
Emerging novel molecular targets in anti-arrhythmic therapy - Basic Science Track
© 2016 European Society of Cardiology. All rights reserved